Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting

Detalles Bibliográficos
Autor principal: Takeda, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475551/
https://www.ncbi.nlm.nih.gov/pubmed/32944373
http://dx.doi.org/10.21037/jtd-2020-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475551/
https://www.ncbi.nlm.nih.gov/pubmed/32944373
http://dx.doi.org/10.21037/jtd-2020-46

Ejemplares similares